Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 732 of 1,261

  1. US 9144608

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  2. US 9145389

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  3. US 9145433

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  4. US 9145366

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  5. US 9144615

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  6. US 9144634

    Medical device with intrapore films

    Covidien LP · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  7. US 9144611

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  8. US 2015265529

    ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 24, 2015 · Expires Sep 19, 2035

    granted

  9. US 9139634

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  10. US 9138416

    Sustained-release nanoparticle compositions and methods using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  11. US 9138479

    Formulations for the treatment of diabetes

    XERIS PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  12. US 9138437

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  13. US 9137973

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  14. US 9139530

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  15. US 9139529

    Substituted quinoxalines as sodium channel modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  16. US 9139598

    Glucokinase activators

    Takeda California, Inc. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  17. US 9139833

    Modified small interfering RNA molecules and methods of use

    Arrowhead Research Corporation · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  18. US 9139644

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  19. US 9140698

    Modulating bacterial MAM polypeptides in pathogenic disease

    The Board of Regents of the University of Texas System · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  20. US 9139834

    RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis

    Arrowhead Research Corporation · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  21. US 9139827

    Polyvalent RNA-nanoparticle compositions

    Northwestern University · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  22. US 9140687

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  23. US 9139595

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  24. US 9139575

    Broad spectrum antiviral and antiparasitic agents

    The Regents of the University of California · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.